Sabrepoint Capital Management

George Baxter, the founder, serves as the sole portfolio manager and makes all investment decisions. Baxter previously led energy and special-situations investing at Highland Capital Management, where he spent over a decade before launching Sabrepoint in 2017. The firm maintains a lean structure specifically so Baxter retains direct oversight of every position.

Sabrepoint targets positions with a defined catalyst expected to materialize within 12 to 18 months — these include spin-offs, post-bankruptcy reorganizations, management changes, or announced strategic reviews. The firm runs a concentrated book, typically holding between 10 and 15 core positions, and takes an activist approach when necessary to accelerate the timeline. Positions are sized on conviction around the specific catalyst, not on sector allocation targets.

Baxter sources ideas through a combination of deep fundamental screening for misunderstood balance sheets and an event-driven calendar tracking corporate actions, court dockets, and regulatory filings. His background in distressed and special-situations investing at Highland Capital gave him a network of restructuring advisors, lawyers, and corporate boards that generates proprietary looks at pre-process situations. The firm does not rely on sell-side research or broker conferences as primary sourcing channels.

Sabrepoint operates exclusively as a direct long/short equity investor. It does not make fund commitments, participate as a limited partner in other vehicles, or allocate capital to external managers. All capital is deployed through a single domestic hedge fund structure focused on publicly traded equities.

Sabrepoint does not co-invest alongside external general partners. The firm's model relies on building concentrated, disclosed stakes in public companies — often crossing the 5% threshold that triggers a 13D filing — and engaging directly with management and boards. This is a unilateral strategy, not a club-deal or co-investment approach.

Sabrepoint is structured as a single domestic hedge fund with annual liquidity. It launched in 2017 with backing from a concentrated group of family offices and high-net-worth individuals who had prior exposure to Baxter's track record at Highland Capital. The firm does not publicly disclose its investor base or total assets under management.

Sabrepoint focuses on energy, real estate, financials, and consumer discretionary, and has not demonstrated activity in technology, healthcare, or biotechnology. The firm's event-driven, balance-sheet-heavy approach favors asset-intensive businesses with hard collateral and identifiable liquidation values — characteristics typically absent from asset-light technology and biotech companies.